Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
EyePoint Pharmaceuticals Inc (EYPT)  
$0.44 0.00 (0.00%) as of 4:30 Tue 12/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 143,520,000
Market Cap: 63.51(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4425 - $0.4425
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   EyePoint Pharmaceuticals is a pharmaceutical company focused on developing and commercializing therapeutics for patients with eye disorders. Co.'s primary product candidate, EYP-19, is a potential sustained delivery intravitreal anti-VEGF treatment targeting wet age-related macular degeneration. YUTIQ 50 (fluocinolone acetonide intravitreal implant) 0.18 mg for intravitreal injection, is for the treatment of non-infectious uveitis affecting the posterior segment of the eye. DEXYCU® (dexamethasone intraocular suspension) 9%, for intraocular administration, is indicated for the treatment of post-operative ocular inflammation.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 581,765 3,944,057 3,944,057 3,944,057
Total Buy Value $10,489,446 $79,414,692 $79,414,692 $79,414,692
Total People Bought 1 1 1 1
Total Buy Transactions 1 5 5 5
Total Shares Sold 209 6,161,499 6,722,029 6,722,029
Total Sell Value $5,954 $121,266,413 $128,353,600 $128,353,600
Total People Sold 1 6 7 7
Total Sell Transactions 1 24 32 32
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 267
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gross Phillip 10% Owner   –       –       •   2024-04-18 3 IO $0.00 $0 I/I 0 5,156,299     -
   Cormorant Global Healthcare Master Fund, Lp   •       •       •   2024-04-18 4 B $17.62 $10,489,446 I/I 581,765 7,475,000 0.01     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2024-03-30 4 D $20.67 $528,036 D/D (25,546) 67,080     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2024-03-30 4 OE $0.00 $0 D/D 50,404 92,626     -
   Duker Jay S. President and CEO   •       •      –    2024-02-27 4 GA $0.00 $0 I/I 2,500 22,500     -
   Duker Jay S. President and CEO   •       •      –    2024-02-27 4 GD $0.00 $0 D/D 2,500 29,420     -
   Duker Jay S. President and CEO   •       •      –    2024-02-20 4 GA $0.00 $0 I/I 20,000 20,000     -
   Duker Jay S. President and CEO   •       •      –    2024-02-20 4 GD $0.00 $0 D/D 20,000 31,920     -
   Lurker Nancy Executive Vice Chair   •       •      –    2024-02-13 4 GA $0.00 $0 I/I 74,681 126,889     -
   Lurker Nancy Executive Vice Chair   •       •      –    2024-02-13 4 GD $0.00 $0 D/D 74,681 83,351     -
   Lurker Nancy Executive Vice Chair   •       •      –    2024-02-09 4 D $28.80 $430,358 D/D (14,943) 158,032     -
   Lurker Nancy Executive Vice Chair   •       •      –    2024-02-09 4 OE $0.00 $0 D/D 37,534 172,975     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2024-02-09 4 D $28.80 $146,390 D/D (5,083) 42,222     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2024-02-09 4 OE $0.00 $0 D/D 10,800 47,305     -
   Elston George Chief Financial Officer   •       –      –    2024-02-09 4 D $28.80 $91,930 D/D (3,192) 43,607     -
   Elston George Chief Financial Officer   •       –      –    2024-02-09 4 OE $0.00 $0 D/D 10,800 46,799     -
   Duker Jay S. President and CEO   •       •      –    2024-02-09 4 D $28.80 $101,750 D/D (3,533) 51,920     -
   Duker Jay S. President and CEO   •       •      –    2024-02-09 4 OE $0.00 $0 D/D 11,967 55,453     -
   Jones David Scott SVP & Chief Commercial Officer   •       –      –    2024-02-09 4 D $28.80 $105,293 D/D (3,656) 44,916     -
   Jones David Scott SVP & Chief Commercial Officer   •       –      –    2024-02-09 4 OE $0.00 $0 D/D 9,967 48,572     -
   Jones David Scott SVP & Chief Commercial Officer   •       –      –    2024-02-02 4 S $28.49 $5,954 D/D (209) 37,962     -
   Jones David Scott SVP & Chief Commercial Officer   •       –      –    2024-02-02 4 OE $11.47 $2,397 D/D 209 38,171     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2024-01-26 4 S $25.41 $1,265,539 D/D (49,325) 36,505     -
   Paggiarino Dario A. Chief Medical Officer   •       –      –    2024-01-26 4 OE $12.90 $644,047 D/D 49,325 85,830     -
   Jones David Scott SVP & Chief Commercial Officer   •       –      –    2024-01-26 4 S $25.27 $660,370 D/D (26,017) 37,962     -
  267 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us